Activity of Indatuximab Ravtansine against Triple-Negative Breast Cancer in Preclinical Tumor Models
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1573-904X
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Activity of Indatuximab Ravtansine against Triple-Negative Breast Cancer in Preclinical Tumor Models ; volume:35 ; number:6 ; day:17 ; month:4 ; year:2018 ; pages:1-10 ; date:6.2018
Pharmaceutical research ; 35, Heft 6 (17.4.2018), 1-10, 6.2018
- Urheber
-
Schönfeld, Kurt
- Beteiligte Personen und Organisationen
-
Herbener, Peter
Zuber, Chantal
Häder, Thomas
Bernöster, Katrin
Uherek, Christoph
Schüttrumpf, Jörg
SpringerLink (Online service)
- DOI
-
10.1007/s11095-018-2400-y
- URN
-
urn:nbn:de:101:1-2018070623064652409427
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:28 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Schönfeld, Kurt
- Herbener, Peter
- Zuber, Chantal
- Häder, Thomas
- Bernöster, Katrin
- Uherek, Christoph
- Schüttrumpf, Jörg
- SpringerLink (Online service)
Ähnliche Objekte (12)
Repurposing mebendazole against triple-negative breast cancer CNS metastasis
Metastatic Triple-Negative Breast Cancer
Characterizing triple-negative breast cancer tumors
Triple-Negative Breast Cancer: Multimodality Appearance
Selinexor (KPT-330) demonstrates anti-tumor efficacy in preclinical models of triple-negative breast cancer
Ferrocenyl Aminocresols Display Multimodal Activity Against Triple‐Negative Breast Cancer Cells In Vitro
MicroRNA signatures in triple-negative breast cancer
Immune-related biomarkers in triple-negative breast cancer
New Vaccine Therapy for Triple-Negative Breast Cancer
Advances in immunotherapy for triple-negative breast cancer
The Triple-Negative Breast Cancer Database: an omics platform for reference, integration and analysis of triple-negative breast cancer data
Trop-2-targeting tetrakis-ranpirnase has potent antitumor activity against triple-negative breast cancer
Repurposing mebendazole against triple-negative breast cancer CNS metastasis
Metastatic Triple-Negative Breast Cancer
Characterizing triple-negative breast cancer tumors
Triple-Negative Breast Cancer: Multimodality Appearance
Selinexor (KPT-330) demonstrates anti-tumor efficacy in preclinical models of triple-negative breast cancer
Ferrocenyl Aminocresols Display Multimodal Activity Against Triple‐Negative Breast Cancer Cells In Vitro
MicroRNA signatures in triple-negative breast cancer
Immune-related biomarkers in triple-negative breast cancer
New Vaccine Therapy for Triple-Negative Breast Cancer
Advances in immunotherapy for triple-negative breast cancer
The Triple-Negative Breast Cancer Database: an omics platform for reference, integration and analysis of triple-negative breast cancer data
Trop-2-targeting tetrakis-ranpirnase has potent antitumor activity against triple-negative breast cancer
Repurposing mebendazole against triple-negative breast cancer CNS metastasis
Metastatic Triple-Negative Breast Cancer
Characterizing triple-negative breast cancer tumors
Triple-Negative Breast Cancer: Multimodality Appearance
Selinexor (KPT-330) demonstrates anti-tumor efficacy in preclinical models of triple-negative breast cancer
Ferrocenyl Aminocresols Display Multimodal Activity Against Triple‐Negative Breast Cancer Cells In Vitro
MicroRNA signatures in triple-negative breast cancer
Immune-related biomarkers in triple-negative breast cancer
New Vaccine Therapy for Triple-Negative Breast Cancer
Advances in immunotherapy for triple-negative breast cancer
The Triple-Negative Breast Cancer Database: an omics platform for reference, integration and analysis of triple-negative breast cancer data